Sol-Gel Technologies (SLGL) Receivables - Net (2017 - 2026)
Sol-Gel Technologies (SLGL) reported Receivables - Net of $1.1 million for Q1 2026, down 72.52% year-over-year from $3.9 million in Q1 2025, and down 45.78% quarter-over-quarter from $2.0 million in Q4 2025.
Sol-Gel Technologies (SLGL) Receivables - Net (2017 - 2026) Analysis & Trends
Sol-Gel Technologies (SLGL) has 10 years of Receivables - Net data on file, last reported at $1.1 million in Q1 2026.
- Receivables - Net for Q1 2026 came in at $1.1 million, down 72.52% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.1 million (down 72.52% YoY), and the FY2025 annual result was $1.4 million, down 60.22% from the prior year.
- Receivables - Net eased to $1.1 million in Q1 2026 per SLGL's latest filing, from $2.0 million in the prior quarter.
- Over five years, Receivables - Net peaked at $10.0 million in Q2 2025 and troughed at $62000.0 in Q4 2022.
- A 5-year average of $4.1 million and a median of $3.6 million in 2024 frame the typical range for Receivables - Net.
- The sharpest annual moves came in 2022 and 2024: Receivables - Net sank 99.53% in 2022, then soared 853.58% in 2024.
- A 5-year view of Receivables - Net shows it stood at $62000.0 in 2022, then jumped by 508.06% to $377000.0 in 2023, then soared by 853.58% to $3.6 million in 2024, then sank by 45.26% to $2.0 million in 2025, then tumbled by 45.78% to $1.1 million in 2026.
- Business Quant data shows SLGL's Receivables - Net at $1.1 million in Q1 2026, $2.0 million in Q4 2025, and $9.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Sol-Gel Technologies | 207.80 Mn | 197.67 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.07 Mn |
| Mar 31, 2026 | 1.07 Mn |
| Dec 31, 2025 | 1.97 Mn |
| Dec 31, 2025 | 1.97 Mn |
| Sep 30, 2025 | 9.85 Mn |
| Sep 30, 2025 | 9.85 Mn |
| Jun 30, 2025 | 10.04 Mn |
| Jun 30, 2025 | 10.04 Mn |
| Mar 31, 2025 | 3.88 Mn |
| Mar 31, 2025 | 3.88 Mn |
| Dec 31, 2024 | 3.60 Mn |
| Dec 31, 2024 | 3.60 Mn |
| Sep 30, 2024 | 7.02 Mn |
| Sep 30, 2024 | 7.02 Mn |
| Jun 30, 2024 | 6.06 Mn |
| Jun 30, 2024 | 6.06 Mn |
| Mar 31, 2024 | 869,000.00 |
| Mar 31, 2024 | 869,000.00 |
| Dec 31, 2023 | 377,000.00 |
| Dec 31, 2023 | 377,000.00 |